Wuxi, China, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) (the "Company") today announced the closing of a best-efforts follow-on public offering of 21,875,000 units (each a "Unit") at an offering price of US$0.112 per Unit. Each Unit consists of one Class A ordinary share of the Company, par value US$0.00002 per share (each, a "Class A Ordinary Share") and one warrant to purchase one Class A Ordinary Share, or up to nine Class A Ordinary Shares pursuant to the alternative cashless exercise mechanism described therein (each, a "Warrant"). Each Warrant has an exercise price of US$0.112 per Class A Ordinary Share and is exercisable beginning on th

Wuxi, China, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) (the "Company") today announced the pricing of a best-efforts follow-on public offering of 21,875,000 units (each a "Unit") at an offering price of US$0.112  per Unit. Each Unit consists of one Class A ordinary share of the Company, par value US$0.00002 per share (each, a "Class A Ordinary Share") and one warrant to purchase one Class A Ordinary Share (or up to nine Class A Ordinary Shares pursuant to the zero exercise price option)  (each, a "Warrant"). Each Warrant will have an exercise price of US$0.112 per Class A Ordinary Share and will be exercisable beginning on the issuance date a

Wuxi, China, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH, the "Company" or "PHH")) announced that the Company will be changing its ticker symbol from "PHH" to "BYAH". Effective on Tuesday October 28, 2025, the Company's ordinary shares will trade on Nasdaq under the new symbol "BYAH". "To prevent potential confusion with a delisted company that used the same symbol, we will officially change the ticker symbol," CEO of the Company, Xiaoqiu Zhang commented. The change of the Company's ticker symbol to ‘BYAH' will have a positive impact on building the Company's long-term brand influence and enhancing our brand value." No action is required by exis

AUSTIN, Texas, July 24, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (NASDAQ:LPRO) ("Open Lending" or the "Company"), an industry trailblazer in automotive lending enablement and risk analytics solutions for financial institutions, today announced the appointment of Massimo Monaco as Chief Financial Officer, effective August 18, 2025. Mr. Monaco brings over two decades of executive finance leadership experience in the residential mortgage lending and financial services industries, and he is known for driving change, strengthening financial discipline, and building strong partnerships with internal and external stakeholders. Most recently, he served as Chief Financial Officer of Arc H

Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) (the "Company"), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the closing of its initial public offering (the "Offering") of 1,200,000 ordinary shares (the "Ordinary Shares") at a public offering price of $4.00 per ordinary share. The Ordinary Shares began trading on the Nasdaq Capital Market on December 27, 2024 under the ticker symbol "PHH." The Company received aggregate gross proceeds of $4.8 million from the Offering, before deducting underwriting discounts and other related expenses payable b

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

F-1/A - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

F-1 - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

S-8 - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

S-8 - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

AUSTIN, Texas, July 24, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (NASDAQ:LPRO) ("Open Lending" or the "Company"), an industry trailblazer in automotive lending enablement and risk analytics solutions for financial institutions, today announced the appointment of Massimo Monaco as Chief Financial Officer, effective August 18, 2025. Mr. Monaco brings over two decades of executive finance leadership experience in the residential mortgage lending and financial services industries, and he is known for driving change, strengthening financial discipline, and building strong partnerships with internal and external stakeholders. Most recently, he served as Chief Financial Officer of Arc H